LINC00887: A Potential Drug Target and Biomarker (G100131551)

Target Name: LINC00887

NCBI ID: G100131551

LINC00887

Other Name(s): long intergenic non-protein coding RNA 887 | HEIRCC | Long intergenic non-protein coding RNA 887

LINC00887: A Potential Drug Target and Biomarker

LINC00887 is a non-coding RNA molecule that has been identified as a potential drug target and biomarker. It is a key regulator of cell adhesion and has been shown to play a role in various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. In this article, we will explore the potential drug target and biomarker properties of LINC00887 and its potential clinical applications.

Potential Drug Target

LINC00887 is a small non-coding RNA molecule that is expressed in various tissues and cells. It is a key regulator of cell adhesion and has been shown to play a role in cell-cell adhesion, as well as cell-tissue adhesion. LINC00887 has been shown to regulate the expression of adhesion molecules, such as cadherin and E-cadherin, which are important for cell-cell and cell-tissue adhesion.

In addition to its role in cell adhesion, LINC00887 has also been shown to play a role in the regulation of cell survival and proliferation. It has been shown to be a negative regulator of the p53 gene, which is a well-known regulator of DNA damage repair and cell survival. LINC00887 has also been shown to regulate the expression of genes involved in cell cycle progression and apoptosis, which may have implications for the regulation of cancer growth and progression.

Potential Biomarker

LINC00887 has also been shown to have potential as a biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. It has been shown to be abnormally expressed in various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. For example, LINC00887 has been shown to be abnormally expressed in various types of cancer, including breast, ovarian, and colorectal cancers.

In addition to its potential as a biomarker, LINC00887 has also been shown to have potential as a drug target. Its role in cell adhesion and the regulation of cell survival and proliferation make it a promising target for small molecule inhibitors. Additionally, its potential as a biomarker for various diseases and its expression abnormality in diseases such as cancer make it a good candidate for diagnostic tests.

Conclusion

In conclusion, LINC00887 is a promising drug target and biomarker. Its role in cell adhesion and the regulation of cell survival and proliferation make it a good candidate for small molecule inhibitors. Additionally, its potential as a biomarker for various diseases and its expression abnormality in diseases such as cancer make it a good candidate for diagnostic tests. Further research is needed to fully understand the potential clinical applications of LINC00887.

Protein Name: Long Intergenic Non-protein Coding RNA 887

The "LINC00887 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC00887 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets